{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:20:22Z","timestamp":1791404422301,"version":"4.3.3"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870157"],"award-info":[{"award-number":["81870157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070219"],"award-info":[{"award-number":["82070219"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270214"],"award-info":[{"award-number":["82270214"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.canlet.2023.216486","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T11:11:54Z","timestamp":1700305914000},"page":"216486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["RNA-binding protein hnRNPU regulates multiple myeloma resistance to selinexor"],"prefix":"10.1016","volume":"580","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingcao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianwen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5855-4343","authenticated-orcid":false,"given":"Yuhuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.canlet.2023.216486_bib1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/jama.2021.25306","article-title":"What is multiple myeloma?","volume":"327","author":"Silberstein","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.canlet.2023.216486_bib2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.canlet.2023.216486_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41375-021-01483-z","article-title":"Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms","volume":"36","author":"Balasubramanian","year":"2022","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.canlet.2023.216486_bib4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.2017.75.5207","article-title":"Selective inhibition of nuclear export with oral selinexor for treatment of relapsed or refractory multiple myeloma","volume":"36","author":"Vogl","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2023.216486_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa1903455","article-title":"Oral selinexor-dexamethasone for triple-class refractory multiple myeloma","volume":"381","author":"Chari","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.canlet.2023.216486_bib6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12916-022-02305-4","article-title":"Selinexor plus low-dose dexamethasone in Chinese patients with relapsed\/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm study","volume":"20","author":"Qiu","year":"2022","journal-title":"BMC Med."},{"issue":"3","key":"10.1016\/j.canlet.2023.216486_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0955-0674(99)80051-9","article-title":"hnRNP complexes: composition, structure, and function","volume":"11","author":"Krecic","year":"1999","journal-title":"Curr. Opin. Cell Biol."},{"issue":"3","key":"10.1016\/j.canlet.2023.216486_bib8","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.18632\/aging.202411","article-title":"Identification of therapeutic targets and prognostic biomarkers from the hnRNP family in invasive breast carcinoma","volume":"13","author":"Zhou","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.canlet.2023.216486_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13046-022-02276-7","article-title":"A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing","volume":"41","author":"Tang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.canlet.2023.216486_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157081","article-title":"ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5","volume":"7","author":"Yang","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2023.216486_bib11","article-title":"Intratumor heterogeneity of MIF expression correlates with extramedullary involvement of multiple myeloma","volume":"11","author":"Xu","year":"2021","journal-title":"Front. Oncol."},{"issue":"23","key":"10.1016\/j.canlet.2023.216486_bib12","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1182\/bloodadvances.2021004695","article-title":"ALCAM-EGFR interaction regulates myelomagenesis","volume":"5","author":"Luo","year":"2021","journal-title":"Blood Adv"},{"issue":"W1","key":"10.1016\/j.canlet.2023.216486_bib13","doi-asserted-by":"crossref","first-page":"W72","DOI":"10.1093\/nar\/gkab393","article-title":"catRAPID omics v2.0: going deeper and wider in the prediction of protein-RNA interactions","volume":"49","author":"Armaos","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"22","key":"10.1016\/j.canlet.2023.216486_bib14","doi-asserted-by":"crossref","first-page":"12900","DOI":"10.1093\/nar\/gkaa1108","article-title":"PDCD2 functions as an evolutionarily conserved chaperone dedicated for the 40S ribosomal protein uS5 (RPS2)","volume":"48","author":"Landry-Voyer","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.canlet.2023.216486_bib15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jbmr.4507","article-title":"Estrogen-responsive gene MAST4 regulates myeloma bone disease","volume":"37","author":"Cui","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.canlet.2023.216486_bib16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1534\/genetics.106.062117","article-title":"Ltv1 is required for efficient nuclear export of the ribosomal small subunit in Saccharomyces cerevisiae","volume":"174","author":"Seiser","year":"2006","journal-title":"Genetics"},{"issue":"5","key":"10.1016\/j.canlet.2023.216486_bib17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1083\/jcb.151.5.1057","article-title":"Nmd3p is a Crm1p-dependent adapter protein for nuclear export of the large ribosomal subunit","volume":"151","author":"Ho","year":"2000","journal-title":"J. Cell Biol."},{"issue":"21","key":"10.1016\/j.canlet.2023.216486_bib18","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood.V122.21.3165.3165","article-title":"XPO1 inhibition disrupts ribosomal subunits assembly and induces multiple myeloma (MM) cell death","volume":"122","author":"Tagoug","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.canlet.2023.216486_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.celrep.2012.02.001","article-title":"Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins","volume":"1","author":"Huelga","year":"2012","journal-title":"Cell Rep."},{"issue":"14","key":"10.1016\/j.canlet.2023.216486_bib20","first-page":"1001","article-title":"The MDM2-p53 interaction","volume":"1","author":"Moll","year":"2003","journal-title":"Mol. Cancer Res."},{"issue":"6","key":"10.1016\/j.canlet.2023.216486_bib21","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1158\/1078-0432.CCR-16-1333","article-title":"Inhibition of the nuclear export receptor XPO1 as a therapeutic target for platinum-resistant ovarian cancer","volume":"23","author":"Chen","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.canlet.2023.216486_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061592","article-title":"Targeting an MDM2\/MYC Axis to overcome drug resistance in multiple myeloma","volume":"14","author":"Faruq","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.canlet.2023.216486_bib23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0092-8674(00)80926-5","article-title":"Nucleocytoplasmic transport: the last 200 nanometers","volume":"92","author":"Ohno","year":"1998","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.canlet.2023.216486_bib24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4149\/neo_2010_05_482","article-title":"Expression of RAN, ZHX-2, and CHC1L genes in multiple myeloma patients and in myeloma cell lines treated with HDAC and Dnmts inhibitors","volume":"57","author":"Legartova","year":"2010","journal-title":"Neoplasma"},{"issue":"Database issue","key":"10.1016\/j.canlet.2023.216486_bib25","doi-asserted-by":"crossref","first-page":"D338","DOI":"10.1093\/nar\/gks936","article-title":"ValidNESs: a database of validated leucine-rich nuclear export signals","volume":"41","author":"Fu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2023.216486_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ceb.2015.04.012","article-title":"Nuclear transport factors: global regulation of mitosis","volume":"35","author":"Forbes","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"issue":"10","key":"10.1016\/j.canlet.2023.216486_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrm2255","article-title":"Exporting RNA from the nucleus to the cytoplasm","volume":"8","author":"Kohler","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.canlet.2023.216486_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13045-020-00903-4","article-title":"XPO1-dependent nuclear export as a target for cancer therapy","volume":"13","author":"Azizian","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2023.216486_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41392-020-00444-9","article-title":"The regulation of protein translation and its implications for cancer","volume":"6","author":"Song","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"6","key":"10.1016\/j.canlet.2023.216486_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41419-019-1627-9","article-title":"XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis","volume":"10","author":"Zhu","year":"2019","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.canlet.2023.216486_bib31","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1158\/0008-5472.CAN-21-4087","article-title":"Ribosome biogenesis: a central player in cancer metastasis and therapeutic resistance","volume":"82","author":"Elhamamsy","year":"2022","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.canlet.2023.216486_bib32","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1158\/1078-0432.CCR-22-3668","article-title":"BRD9 degradation disrupts ribosome biogenesis in multiple myeloma","volume":"29","author":"Kurata","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"389","key":"10.1016\/j.canlet.2023.216486_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2668","article-title":"Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma","volume":"9","author":"Manier","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2023.216486_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108722","article-title":"Drug resistance biomarker ABCC4 of selinexor and immune feature in multiple myeloma","volume":"108","author":"Hu","year":"2022","journal-title":"Int. Immunopharm."},{"issue":"12","key":"10.1016\/j.canlet.2023.216486_bib35","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1182\/bloodadvances.2021006638","article-title":"Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects","volume":"7","author":"Li","year":"2023","journal-title":"Blood Adv"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523004378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523004378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:12:00Z","timestamp":1759594320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383523004378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":35,"alternative-id":["S0304383523004378"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216486","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA-binding protein hnRNPU regulates multiple myeloma resistance to selinexor","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"216486"}}